NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Retrospective Epidemiological Study of Locally Advanced Non Small Cell Lung Cancer Patients in Brazil

CompletedN/A

Sponsor: Latin American Cooperative Oncology Group

Conditions: Lung Cancer, Non-small Cell

Countries: Brazil

RELANCE is a large multi-institutional study that aims to retrospectively collect information about diagnostic, treatment and outcome of patients diagnosed with locally advanced NSCLC in Brazil. It is hypothesized that there is a great heterogeneity in treatment patterns owing to inequities in access to adequate staging methods, optimal treatment and multidisciplinary teams in Brazil.

Eligibility overview

Sex: ALL

Age: 18 Years to —

Healthy volunteers: No

Study type: OBSERVATIONAL

Eligibility criteria

Inclusion Criteria:

1. Patients aged 18 years or older;
2. Histologically or cytological diagnosis of NSCLC in the period of January 2015 to December 2016;
3. Locally Advanced NSCLC defined as clinical stage IIIA and IIIB according to 7th Edition TNM Staging System;
4. Any NSCLC histological subtype and molecular mutation;
5. Any Eastern Cooperative Oncology Group (ECOG) Performance Status (0 to 4) at diagnosis;
6. Patients assigned by treating physician to any therapy or palliative care;
7. Access to patient medical chart for data collection.

Exclusion Criteria:

1. Small cell lung cancer and non-invasive NSCLC;
2. Synchronic NSCLC or second primary tumour in the last 5 years (except non-melanoma skin cancer).

Locations (1)

São Paulo, São Paulo, Brazil